fbpx

alpHaONE Wireless pH Capsule Reflux Monitoring System 

alpHaONE Wireless pH Capsule Reflux Monitoring System 

alpHaONE Wireless pH Capsule Reflux Monitoring System for the Treatment of GERD

Contact Us


As options for detecting gastroesophageal reflux disease (GERD) continue to increase, patients and healthcare providers are faced with the challenge of selecting the best solution for a clear and accurate diagnosis.

The alpHaONE system offers wireless reflux testing for up to 96 hours, transmitting data via radio frequency to a recorder that is then analyzed using the pH Capsule System’s software.

This data provides healthcare professionals with the necessary information for accurate diagnoses and effective treatment plans. Additionally, the alpHaONE system’s user-friendly design ensures a comfortable experience for patients undergoing reflux monitoring. 

To request more information or to receive a quote, please contact us.


alpHaONE Wireless pH Capsule Reflux Monitoring System for the Treatment of GERD

 

Recorder: 

  • Ergonomic and compact design 
  • Patient-friendly design with enlarged and easy-to-press buttons 
  • Battery operated allowing for immediate patient utilization 

 Capsule: 

  • Calibration-free and up to 96 hours comprehensive recording 
  • Easy handling and fail-safe mechanism for capsule attachment  
  • Smooth conveyor tip to avoid injury during placement 

Software: 

  • All-in-one software application with Virtual Instruction Program (VIP) for intuitive navigation 
  • User-definable symptom buttons 
  • Automatic analysis of pH data 

 

alpHaONE Wireless pH Capsule Reflux Monitoring System for the Treatment of GERD
GI Icon OB Icon UR Icon

Indications For Use

The pH Capsule System is indicated for use with the following patient candidates:  

  • Patients who experience classic symptoms of acid reflux or heartburn and are considered as Gastroesophageal Reflux Disease (GERD) patients.
  • Patients who suffer from unexplained chronic pharyngitis, hoarseness, tracheitis, or asthma and are considered as patients having extra esophageal symptoms of GERD.  
  • Patients undergoing PPI treatment for whom a healthcare professional needs to determine the effectiveness of the treatment.  

139383 – 0

139383 – 0

Follow Us